GO:1902173 negative regulation of keratinocyte apoptotic process: Apoptosis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902173 describes any process that stops, prevents, or reduces the frequency, rate, or extent of keratinocyte apoptotic process.
• Keratinocyte apoptosis is a tightly regulated event essential for epidermal homeostasis, wound healing, and immune balance.
• Key negative regulators include PRELP, PFN1, Livin, FOXO3a, and JNK2, which modulate survival signaling in keratinocytes.
• Dysregulation of this process contributes to psoriasis, impaired wound healing, and skin cancer.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of these regulators.
• Targeting negative regulators of keratinocyte apoptosis offers therapeutic potential for inflammatory skin diseases and chronic wounds.
Description
The Gene Ontology term GO:1902173, negative regulation of keratinocyte apoptotic process, refers to any biological process that stops, prevents, or reduces the frequency, rate, or extent of apoptosis in keratinocytes. Keratinocytes are the predominant cell type of the epidermis, and their programmed cell death is a fundamental mechanism for maintaining skin barrier integrity, immune surveillance, and tissue repair. Apoptosis of keratinocytes must be tightly controlled; excessive apoptosis can lead to epidermal thinning and impaired wound healing, while insufficient apoptosis can promote hyperproliferation and inflammation. Understanding the negative regulators of this process is therefore critical for skin biology and disease research. Recent studies have identified several proteins that negatively regulate keratinocyte apoptosis. For example, PRELP (proline/arginine-rich end leucine-rich repeat protein) negatively regulates IL-17A-mediated proliferation and inflammatory responses in psoriasis, indirectly influencing keratinocyte survival. PFN1 (profilin-1) prevents psoriasis pathogenesis through IκBζ regulation, suggesting a role in suppressing apoptotic and inflammatory pathways. Livin, an inhibitor of apoptosis protein, promotes keratinocyte release of inflammatory mediators in psoriasis, indicating that its anti-apoptotic function may exacerbate disease. FOXO3a, a transcription factor, is negatively regulated by mTORC2 to induce a pro-survival response following UVB irradiation, directly linking survival signaling to apoptosis inhibition. JNK2 has been characterized as a negative regulator of cellular proliferation, with implications for keratinocyte homeostasis. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:1902173, covering its definition, mechanisms, key genes, disease relevance, and experimental models. It is designed for researchers seeking to understand or manipulate this process using CRISPR-based tools and functional genomics.
negative regulation of keratinocyte apoptotic process At A Glance
| GO ID | GO:1902173 |
|---|---|
| GO term | negative regulation of keratinocyte apoptotic process |
| Ontology | biological_process |
| Synonym | down regulation of keratinocyte apoptosis; inhibition of keratinocyte apoptotic process; downregulation of keratinocyte apoptosis |
| Major function | Suppression of programmed cell death in keratinocytes to maintain epidermal homeostasis and tissue repair |
| Related processes | Apoptotic process, keratinocyte differentiation, wound healing, inflammatory response |
| Key regulators | PRELP, PFN1, Livin, FOXO3a, JNK2, mTORC2 |
| Disease relevance | Psoriasis, diabetic foot ulcers, skin cancer, impaired wound healing |
What Is GO:1902173?
GO:1902173 is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of keratinocyte apoptotic process. In simpler terms, it encompasses all molecular events that protect keratinocytes from undergoing programmed cell death. This regulation is essential for normal skin development, wound healing, and immune homeostasis, and its disruption is associated with inflammatory skin diseases and impaired tissue repair.
Why Is negative regulation of keratinocyte apoptotic process Important in Cell Biology?
Negative regulation of keratinocyte apoptosis is critical for skin homeostasis because it balances cell survival and death to maintain an intact epidermal barrier. Dysregulation of this process is directly implicated in inflammatory skin diseases such as psoriasis, where excessive survival signaling promotes hyperproliferation and inflammation. Conversely, insufficient negative regulation can lead to excessive apoptosis, contributing to chronic wounds and impaired healing. Understanding the molecular players and mechanisms of this GO term is therefore essential for developing targeted therapies for skin disorders and for advancing regenerative medicine.
• Maintains epidermal barrier integrity by preventing excessive keratinocyte death.
• Modulates inflammatory responses in psoriasis through regulators like PRELP and PFN1.
• Influences wound healing outcomes, including diabetic foot ulcers.
• Protects against UVB-induced apoptosis via FOXO3a and mTORC2 signaling.
• Controls keratinocyte proliferation and survival through JNK2 and Livin.
• Provides therapeutic targets for inflammatory skin diseases and chronic wounds.
• Serves as a model for studying apoptosis regulation in epithelial cells.
• Enables CRISPR-based functional genomics to identify novel regulators.
What Happens During negative regulation of keratinocyte apoptotic process?
Initiation of survival signaling
In simple terms: Cells receive signals that tell them to stay alive.
Negative regulation of keratinocyte apoptosis begins with the activation of survival signaling pathways. For instance, mTORC2 negatively regulates FOXO3a, a transcription factor that would otherwise promote apoptosis, thereby inducing a pro-survival response following UVB irradiation. Similarly, PRELP negatively regulates IL-17A-mediated proliferation and inflammatory responses, indirectly supporting keratinocyte survival in psoriasis. These signals converge on mitochondria and other organelles to block the intrinsic apoptotic pathway.
Inhibition of pro-apoptotic factors
In simple terms: Pro-death proteins are blocked or degraded.
A key step is the suppression of pro-apoptotic proteins such as BAX and BAK, and the activation of anti-apoptotic proteins like Livin. Livin, an inhibitor of apoptosis protein, is expressed in keratinocytes and promotes release of inflammatory mediators in psoriasis, indicating that its anti-apoptotic function is linked to disease pathogenesis. PFN1 prevents psoriasis pathogenesis through IκBζ regulation, which may involve suppression of apoptotic signaling. JNK2 has been characterized as a negative regulator of cellular proliferation, suggesting it may influence apoptosis indirectly.
Maintenance of mitochondrial integrity
In simple terms: Mitochondria are kept intact to prevent cell death.
Mitochondrial outer membrane permeabilization is a point of no return in apoptosis. Negative regulation of keratinocyte apoptosis involves maintaining mitochondrial integrity through the action of anti-apoptotic BCL-2 family proteins and inhibition of cytochrome c release. FOXO3a, when not phosphorylated by mTORC2, can translocate to the nucleus and induce pro-apoptotic genes; thus, mTORC2-mediated phosphorylation of FOXO3a prevents this cascade. This mechanism is particularly relevant in UVB-exposed keratinocytes.
Modulation of inflammatory and immune cross-talk
In simple terms: Survival signals also calm inflammation.
Keratinocyte apoptosis is closely linked to inflammatory signaling. PRELP negatively regulates IL-17A-mediated proliferation and inflammatory response in psoriasis, indicating that it may simultaneously suppress apoptosis and inflammation. Livin expression promotes keratinocyte release of inflammatory mediators, suggesting that anti-apoptotic proteins can exacerbate inflammation. PFN1 prevents psoriasis pathogenesis through IκBζ regulation, linking survival to NF-κB signaling. Thus, negative regulation of apoptosis is intertwined with immune modulation in the skin.
Autophagy and stress adaptation
In simple terms: Cells recycle damaged parts to survive stress.
Autophagy and skin wound healing are intimately connected; autophagy can promote keratinocyte survival under stress conditions. Negative regulation of apoptosis may involve autophagy-mediated clearance of damaged organelles and proteins, reducing apoptotic triggers. In diabetic foot ulcers, negative pressure wound therapy regulates RNA-binding proteins FUS and ILF2, which may influence keratinocyte survival and apoptosis. This highlights the integration of stress adaptation pathways with apoptosis regulation.
Key Genes Involved in GO:1902173 negative regulation of keratinocyte apoptotic process
The following genes and proteins have been experimentally implicated in the negative regulation of keratinocyte apoptotic process, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRELP | Negatively regulates IL-17A-mediated proliferation and inflammation in psoriasis | Potential therapeutic target for psoriasis; modulates keratinocyte survival |
| PFN1 | Prevents psoriasis pathogenesis through IκBζ regulation | Links actin dynamics to apoptosis suppression |
| Livin (BIRC7) | Inhibitor of apoptosis protein; promotes inflammatory mediator release | Anti-apoptotic function in keratinocytes; psoriasis |
| FOXO3a | Transcription factor negatively regulated by mTORC2; pro-survival after UVB | UVB response; apoptosis inhibition |
| JNK2 (MAPK9) | Negative regulator of cellular proliferation | May influence keratinocyte apoptosis indirectly |
| mTORC2 | Kinase complex that phosphorylates FOXO3a | Survival signaling in UVB-exposed keratinocytes |
| FUS | RNA-binding protein regulated by negative pressure wound therapy | Diabetic foot ulcer healing; apoptosis modulation |
| ILF2 | RNA-binding protein regulated by negative pressure wound therapy | Diabetic foot ulcer healing |
| Stratifin (SFN) | 14-3-3 sigma; involved in fibroblast-keratinocyte interaction | May influence keratinocyte survival |
| BCL-2 family (e.g., BCL-2, BCL-xL) | Anti-apoptotic proteins | General apoptosis regulation in keratinocytes |
| Caspase-3 | Executioner caspase | Apoptosis marker; negatively regulated |
| Caspase-8 | Initiator caspase | Extrinsic apoptosis pathway |
| IκBζ (NFKBIZ) | Transcription factor regulated by PFN1 | Psoriasis pathogenesis |
| IL-17A | Pro-inflammatory cytokine | Psoriasis; regulated by PRELP |
| TNF-α | Pro-inflammatory cytokine | Can induce apoptosis; counteracted by survival signals |
| UVB | Environmental stressor | Induces apoptosis; FOXO3a/mTORC2 pathway |
| Autophagy-related genes (e.g., ATG5, ATG7) | Autophagy machinery | Promote survival in wound healing |
How Is negative regulation of keratinocyte apoptotic process Regulated?
The negative regulation of keratinocyte apoptotic process is controlled by multiple signaling pathways. The mTORC2-AKT axis phosphorylates FOXO3a, preventing its nuclear translocation and subsequent induction of pro-apoptotic genes. Inflammatory cytokines such as IL-17A can promote proliferation and survival, but this is counteracted by PRELP. PFN1 modulates IκBζ, affecting NF-κB signaling and survival. Livin, an IAP family member, directly inhibits caspases. JNK2 may act as a negative regulator of proliferation, indirectly influencing apoptosis. Additionally, autophagy and stress-responsive RNA-binding proteins like FUS and ILF2 contribute to survival under wound healing conditions. These pathways are context-dependent and often cross-talk, forming a complex regulatory network.
negative regulation of keratinocyte apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRELP | Psoriasis | Knockout and overexpression in HaCaT cells; IL-17A stimulation |
| PFN1 | Psoriasis | Knockout in primary keratinocytes; IκBζ reporter |
| Livin (BIRC7) | Psoriasis | Overexpression and knockout in keratinocytes; inflammatory mediator release |
| FOXO3a | UVB response / skin cancer | Point mutation of mTORC2 phosphorylation sites; UVB irradiation |
| FUS/ILF2 | Diabetic foot ulcer | Knockdown in keratinocytes under negative pressure; wound healing assays |
Psoriasis
Psoriasis is a chronic inflammatory skin disease characterized by hyperproliferation and abnormal keratinocyte apoptosis. PRELP negatively regulates IL-17A-mediated proliferation and inflammatory response, and its dysregulation may contribute to psoriasis pathogenesis. PFN1 prevents psoriasis pathogenesis through IκBζ regulation, suggesting that loss of PFN1 could enhance apoptosis and inflammation. Livin expression promotes keratinocyte release of inflammatory mediators, linking anti-apoptotic function to disease severity. Thus, negative regulation of keratinocyte apoptosis is a double-edged sword in psoriasis: insufficient apoptosis can drive hyperproliferation, while excessive inflammation may exacerbate tissue damage.
Wound healing and diabetic foot ulcers
Impaired wound healing, particularly in diabetic foot ulcers, is associated with dysregulated keratinocyte apoptosis. Autophagy and skin wound healing are closely linked, and negative regulation of apoptosis may promote keratinocyte survival and re-epithelialization. Negative pressure wound therapy regulates FUS and ILF2 RNA-binding proteins, which may enhance keratinocyte survival and accelerate healing. Therefore, strategies to boost negative regulation of apoptosis could improve outcomes in chronic wounds.
UVB-induced skin damage and cancer
UVB irradiation induces keratinocyte apoptosis, which is a protective mechanism against skin cancer. However, excessive apoptosis can cause skin damage. FOXO3a is negatively regulated by mTORC2, leading to a pro-survival response following UVB exposure. This pathway may contribute to resistance to apoptosis in pre-malignant keratinocytes, potentially promoting skin carcinogenesis. Understanding the balance between survival and death is critical for developing chemopreventive strategies.
From negative regulation of keratinocyte apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PRELP inhibit keratinocyte apoptosis? | PRELP knockout and overexpression in HaCaT cells; annexin V/PI staining |
| Is PFN1 required for survival? | PFN1 knockout in primary keratinocytes; caspase-3 activity assay |
| Does Livin protect against apoptosis? | Livin overexpression and shRNA knockdown; TNF-α induced apoptosis |
| How does FOXO3a phosphorylation affect survival? | FOXO3a point mutant (phospho-deficient) knock-in; UVB treatment |
| What is the role of JNK2 in apoptosis? | JNK2 knockout keratinocytes; proliferation and apoptosis assays |
| Can autophagy modulate apoptosis? | ATG5 or ATG7 knockout; starvation and wound healing models |
How to Study the negative regulation of keratinocyte apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V/PI staining | Phosphatidylserine externalization and membrane integrity | Quantify apoptosis in knockout/overexpression keratinocytes |
| Caspase-3/7 activity assay | Executioner caspase activity | Confirm apoptosis induction or inhibition |
| TUNEL | DNA fragmentation | Detect apoptotic cells in tissue sections |
| RNA-seq | Global transcriptome changes | Identify survival pathways regulated by PRELP or PFN1 |
| Proteomics | Protein abundance and modifications | Study FOXO3a phosphorylation after UVB |
| Confocal microscopy | Subcellular localization | Track FOXO3a nuclear translocation |
| Immunohistochemistry | Protein expression in tissue | Assess PRELP, PFN1, Livin in psoriasis skin |
| CRISPR library screen | Gene essentiality for survival | Discover novel negative regulators of apoptosis |
Apoptosis assays
Annexin V/propidium iodide staining, TUNEL, and caspase-3/7 activity assays are standard for quantifying keratinocyte apoptosis. These methods can be applied to cells with CRISPR-mediated knockout or overexpression of candidate genes to determine their role in negative regulation.
Transcriptomics and proteomics
RNA-seq and proteomics can identify global changes in gene expression and protein abundance upon modulation of negative regulators. For example, RNA-seq of PRELP-knockout keratinocytes treated with IL-17A can reveal downstream survival pathways. Proteomic analysis of FOXO3a mutants after UVB can uncover phosphorylation-dependent targets.
Imaging and immunohistochemistry
Confocal microscopy with fluorescently tagged proteins (e.g., GFP-FOXO3a) can visualize subcellular localization during apoptosis. Immunohistochemistry of skin biopsies from psoriasis patients can assess expression of PRELP, PFN1, and Livin in situ.
Functional genomics screens
CRISPR library screens can systematically identify genes that negatively regulate keratinocyte apoptosis. For instance, a genome-wide knockout screen followed by apoptosis induction (e.g., UVB or TNF-α) can uncover novel survival factors.
How CRISPR Can Be Used to Study GO:1902173 negative regulation of keratinocyte apoptotic process
Knockout
CRISPR knockout of candidate genes such as PRELP, PFN1, or Livin in keratinocytes can determine whether they are required for negative regulation of apoptosis. For example, PRELP knockout may sensitize cells to IL-17A-induced apoptosis. PFN1 knockout could increase IκBζ-mediated apoptosis. Livin knockout may enhance TNF-α-induced cell death.
Point Mutation
Point mutations can dissect specific phosphorylation sites or catalytic residues. For FOXO3a, mutating mTORC2 phosphorylation sites (e.g., T32, S253) to alanine prevents phosphorylation and promotes nuclear translocation, enhancing apoptosis. Such models are invaluable for understanding signaling dynamics.
Knock-in
Knock-in of tagged versions (e.g., GFP or HA) of genes like FOXO3a or PFN1 allows real-time tracking of protein localization and interactions. This can reveal how these proteins shuttle between cytoplasm and nucleus during apoptosis regulation.
Overexpression
Overexpression of anti-apoptotic genes such as Livin or PRELP in keratinocytes can protect against apoptosis and reduce inflammation. For instance, Livin overexpression promotes inflammatory mediator release, mimicking psoriasis-like phenotypes. PRELP overexpression suppresses IL-17A-mediated proliferation.
How EDITGENE Supports negative regulation of keratinocyte apoptotic process Research
Researchers studying negative regulation of keratinocyte apoptotic process-related genes often need to determine whether a candidate gene is causally involved in survival or death pathways. This requires precise genetic manipulation, functional assays, and unbiased screening approaches. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of keratinocyte apoptotic process research.
Frequently Asked Questions About negative regulation of keratinocyte apoptotic process
What is GO:1902173?
GO:1902173 is the Gene Ontology term for negative regulation of keratinocyte apoptotic process, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of apoptosis in keratinocytes.
What genes are involved in negative regulation of keratinocyte apoptotic process?
Key genes include PRELP, PFN1, Livin (BIRC7), FOXO3a, JNK2, and mTORC2, among others.
How does PRELP affect keratinocyte apoptosis?
PRELP negatively regulates IL-17A-mediated proliferation and inflammatory response in psoriasis, indirectly supporting keratinocyte survival.
What is the role of FOXO3a in keratinocyte apoptosis?
FOXO3a is a transcription factor that promotes apoptosis; its negative regulation by mTORC2 phosphorylation induces a pro-survival response after UVB irradiation.
How is Livin involved in psoriasis?
Livin, an inhibitor of apoptosis protein, is expressed in keratinocytes and promotes release of inflammatory mediators in psoriasis, linking anti-apoptotic function to disease.
Can CRISPR be used to study negative regulation of keratinocyte apoptosis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of genes like PRELP, PFN1, and FOXO3a in keratinocyte apoptosis.
What diseases are associated with dysregulated keratinocyte apoptosis?
Psoriasis, diabetic foot ulcers, UVB-induced skin damage, and skin cancer are associated with altered negative regulation of keratinocyte apoptosis.
What methods measure keratinocyte apoptosis?
Annexin V/PI staining, caspase-3/7 activity assays, TUNEL, and flow cytometry are commonly used to quantify apoptosis.
How does PFN1 prevent psoriasis?
PFN1 prevents psoriasis pathogenesis through regulation of IκBζ, which may suppress apoptotic and inflammatory pathways in keratinocytes.
What is the role of autophagy in keratinocyte apoptosis?
Autophagy promotes skin wound healing and can enhance keratinocyte survival under stress, thereby negatively regulating apoptosis.
Conclusion
GO:1902173, negative regulation of keratinocyte apoptotic process, is a critical biological process that maintains skin homeostasis by preventing excessive keratinocyte death. Key regulators such as PRELP, PFN1, Livin, FOXO3a, and JNK2 modulate survival signaling and inflammatory cross-talk, with direct implications for psoriasis, wound healing, and UVB responses. Dysregulation of this process contributes to chronic inflammatory skin diseases and impaired tissue repair, making it an attractive therapeutic target. CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, are indispensable for dissecting the causal roles of these genes. EDITGENE provides end-to-end services to accelerate such research, from custom cell line generation to CRISPR library screening and bioinformatics analysis. By leveraging these tools, researchers can uncover novel regulators and translate findings into clinical applications for skin disorders.
References
- 1. He CC et al.. 2026. PRELP negatively regulates IL-17A-mediated proliferation and the inflammatory response in psoriasis.. Signal Transduct Target Ther 11(1) PMID: 42204138
- 2. Ren H et al.. 2022. Autophagy and skin wound healing.. Burns Trauma 10:tkac003 PMID: 35187180
- 3. Medina A et al.. 2007. The role of stratifin in fibroblast-keratinocyte interaction.. Mol Cell Biochem 305(1-2):255-64 PMID: 17646930
- 4. Sabapathy K et al.. 2004. JNK2: a negative regulator of cellular proliferation.. Cell Cycle 3(12):1520-3 PMID: 15611655
- 5. Tang Y et al.. 2024. Enhancing diabetic foot ulcer healing: Impact of the regulation of the FUS and ILF2 RNA‑binding proteins through negative pressure wound therapy.. Int J Mol Med 54(5) PMID: 39301661
- 6. Che D et al.. 2024. Livin expression promotes keratinocyte release of inflammatory mediators in psoriasis.. Skin Res Technol 30(2):e13603 PMID: 38332513
- 7. Mok BR et al.. 2022. PFN1 Prevents Psoriasis Pathogenesis through IκBζ Regulation.. J Invest Dermatol 142(9):2455-2463.e9 PMID: 35148999
- 8. Feehan RP et al.. 2016. Negative regulation of the FOXO3a transcription factor by mTORC2 induces a pro-survival response following exposure to ultraviolet-B irradiation.. Cell Signal 28(8):798-809 PMID: 27058291
